Good update from the company.

Everything seems to be going well, It is always nice to see insiders adding shares in the recent price drop. shows their confidence. I am also adding here and there. In a year max this will definately be around the target price of $ 2.00 when Phase II results will be out and all other trials starting out and we should also have formalized some of the agreements by then